Hematology

Hematology Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Federico Spataro • Vanessa Desantis • Giuseppe Dicuonzo • Angelo Vacca • Roberto Ria • Claudio Cerchione • Antonio Giovanni Solimando
doi.org/10.69690/odmj-012-0426-7512
Hematology Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Zayan Alidina • Saad Nasir • Faiza Ahmed • Munira Moosajee
doi.org/10.69690/ODMJ-011-0426-7452
Hematology Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia and Multi-Drug Resistant Bacterial Infections – A Case Series
Farah Malaeb • Walid Ballourah • Laila Alawdah • Murtada Alsultan • Muhammad Ameen • Fahad Almanjomi • Dayel AlShahrani • Abdulrahman Alsultan
doi.org/10.69690/ODMJ-011-0426-7442
Hematology Setting up a Bone Marrow Transplant Unit in A Resource-Limited Country: Challenges and Learnings
Safia Khan • Mussawair Hussain • Fayyaza Hussain
doi.org/10.69690/ODMJ-001-1229-6145
Hematology Osteomyelitis in Children with Sickle Cell Disease: Is MRI pathognomonic?
Murtadha Mohammed Shihab Al Lawati • Zaid Al Hinai • Sameer Raniga • Ahmed Al Kharus • Ahmed Al Shukaili • Shuwaikha Al Manwari • Yaser Wali
doi.org/10.69690/ODMJ-001-1222-5970
Hematology The Experience of Hematologic Oncology in Armenia
Alisa Movsisyan • Liana Hambardzumyan • Nerses Ghahramanyan • Nare Martirosyan • Maria Badikyan • Hayk Grigoryan • Anahit Ter-Grigoryan • Gevorg Saghumyan • Levon Evoyan • Lusine Harutyunyan • Armine Farmazyan • Anna Sevoyan • Karen Meliksetyan • Miranush Saaryan • Yervand Hakobyan • Marine Melik-Andreasyan • Hasmik Oseyan • Amalya Chakhoyan • Avetis Darbinyan • Meri Movsisyan • Lusine Hakobyan • Lusine Krmoyan • Tatul Saghatelyan • Anush Sargsyan • Lusine Sahakyan • Nelly Sargsyan • Heghine Khachatryan • Lilit Petrosyan • Samvel Bardakhchyan • Karen Bedirian • Narine Ghazaryan • Lilit Sargsyan • Narek Manukyan • Armen Muradyan • Gevorg Tamamyan • Samvel Danielyan • Astghik Voskanyan
doi.org/10.69690/ODMJ-001-1124-250
Hematology New Leukaemia Drugs
Robert Peter Gale
doi.org/10.69690/ODMJ-003-0924-142